Notícias · Recifes

Trial of potential Ebola treatments begins in DR Congo: WHO

The trial of two potential treatments for the Bundibugyo species of Ebola behind the deadly outbreak in the DR Congo began in the country Thursday, the World Health Organization said.

Admin Recifes 15/07/2026 2

Aphantasia challenges a centuries-old theory of abstract thought

Aphantasia, the inability to form mental images, poses a serious challenge to an influential theory of abstract thought in the history of philosophy. The study by researchers at the University of Tartu suggests that mental imagery may play a less central role in human thought tha

Admin Recifes 15/07/2026 2

Precision fMRI maps prefrontal cortex in individuals, revealing fine-scale structures

Much like camera settings—filters, flashes and focus—affect what we notice in a final photo, the way scientists measure something can affect how we interpret and understand it. This is especially true when imaging things that we can't see on our own, such as activity in the human

Admin Recifes 15/07/2026 2

FDA lets 20 ZYN nicotine pouches claim lower risk than cigarettes; critics warn of danger

The U.S. Food and Drug Administration (FDA) has authorized marketing of 20 ZYN nicotine pouch products as a lower-risk option than cigarettes, a decision that drew immediate criticism from anti-cancer advocates worried about youth use.

Admin Recifes 15/07/2026 2

Dynamic protein behavior drives blood-brain barrier specialization, study reveals

A study led by researchers at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Proteomics Platform of the Institute for Research in Biomedicine (IRB Barcelona), has uncovered a key mechanism that helps define how the blood-brain barrier functions—no

Admin Recifes 15/07/2026 2

Men should speed up slower to avoid 'hitting the wall' in marathons, new research suggests

Male runners may be twice as likely as female runners to suddenly slow down—known as "hitting the wall"—during a marathon, according to a study published in Scientific Reports. The authors suggest that men may be able to reduce this risk by starting races more slowly and speeding

Admin Recifes 15/07/2026 2

Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.

Admin Recifes 15/07/2026 2

Hybrid work improves the work experience—particularly for women

The transition to hybrid work has improved the psychosocial work environment among white-collar employees, according to new research from Umeå University. Positive effects include more accessible leadership, greater autonomy over work tasks and an increased ability to complete wo

Admin Recifes 15/07/2026 2

Researchers call for increased screening for parasitic disease linked to HIV and cervical

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.

Admin Recifes 15/07/2026 2

Two prostate cancer mutations reveal opposite responses to ferroptosis therapy

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guid

Admin Recifes 15/07/2026 2

Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM

For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study published online June 30 in the Annals of Internal Medi

Admin Recifes 15/07/2026 2

New drug unlocks elusive immune receptor, opening path toward motor neuron disease treatme

University of Queensland researchers have developed a drug that activates a hard-to-target immune receptor—a breakthrough that could lead to new treatments for neurodegenerative conditions like motor neuron disease (MND).

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes